Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDSensei Biotherapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.29 | -$0.29 | -$0.29 |
| Q2 2024 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q3 2024 | 2 | -$0.30 | -$0.26 | -$0.28 |
| Q1 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q2 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q4 2025 | 1 | -$0.11 | -$0.11 | -$0.11 |
Sensei Biotherapeutics, Inc. Earnings Date And Information
Sensei Biotherapeutics, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.29 earnings per share for the quarter, topping analysts' consensus estimates of $-0.31 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Sensei Biotherapeutics, Inc. has generated $-1 earnings per share over the last year ($-1.22 diluted earnings per share) and currently has a price-to-earnings ratio of -0.38. Sensei Biotherapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Sensei Biotherapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.31 | -$0.29 | 0.02 | $0 | $0 |
| 08/06/2024 | Q2 2024 | -$0.25 | -$0.28 | -0.03 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$0.29 | -$0.32 | -0.03 | $0 | |
| 02/29/2024 | Q4 2023 | -$0.30 | $2.85 M | |||
| 11/07/2023 | Q3 2023 | -$0.28 | -$0.28 | 0 | $0 | |
| 08/03/2023 | Q2 2023 | -$0.32 | -$0.31 | 0.01 | $0 | |
| 05/09/2023 | Q1 2023 | -$0.35 | -$0.29 | 0.06 | $0 | |
| 05/01/2023 | Q4 2022 | -$0.40 | $0 | |||
| 11/08/2022 | Q3 2022 | -$0.37 | -$0.42 | -0.05 | $0 | |
| 08/09/2022 | Q2 2022 | -$0.40 | -$0.34 | 0.06 | $0 | |
| 05/10/2022 | Q1 2022 | -$0.35 | -$0.40 | -0.05 | $0 | |
| 03/15/2022 | Q4 2021 | -$0.31 | $0 | |||
| 11/10/2021 | Q3 2021 | -$0.32 | $0 | |||
| 08/11/2021 | Q2 2021 | -$0.32 | $0 | |||
| 05/13/2021 | Q1 2021 | -$0.42 | $0 | |||
| 03/30/2021 | Q4 2020 | -$0.27 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.44 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.40 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.38 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.54 | $0 |
Sensei Biotherapeutics, Inc. Earnings: FAQ's
When is Sensei Biotherapeutics, Inc.'s earnings date?
Sensei Biotherapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
Did Sensei Biotherapeutics, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Sensei Biotherapeutics, Inc. (:SNSE) reported $-0.29 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.31 by $0.02.
How can I listen to Sensei Biotherapeutics, Inc.'s earnings conference
call?
The conference call for Sensei Biotherapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Sensei Biotherapeutics, Inc.'s conference call transcript?
The conference call transcript for Sensei Biotherapeutics, Inc.'s latest earnings report can be read online.
How much profit does Sensei Biotherapeutics, Inc. generate each year?
Sensei Biotherapeutics, Inc. (:SNSE) has a recorded net income of $0. Sensei Biotherapeutics, Inc. has generated $-1.22 earnings per share over the last four quarters.
What is Sensei Biotherapeutics, Inc.'s price-to-earnings ratio?
Sensei Biotherapeutics, Inc. (:SNSE) has a price-to-earnings ratio of -0.38 and price/earnings-to-growth ratio is 0.45.